Anktiva, according to its ImmunityBio, is the first FDA-approved immunotherapy that activates what’s called a natural killer cell to target and kill non-muscle-invasive bladder cancer cells. More: https://www.newsnationnow.com/health/newsnation-special-killing-cancer-treatment-soon-shiong/ | NewsNation